In our results, progesterone interacted with PTEN and MAPK1. Results of a systematic review and meta-analysis indicated that metformin has the strongest evidence for enhancing menstrual cycles, glucose levels, and adiposity in PCOS, notably when incorporated alongside lifestyle adjustments (52, 53). The gene discussed is MAPK1; the disease is polycystic ovary syndrome.